MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clnesp.2026.105069

Медицинская библиотека · Clinical nutrition ESPEN · 2026

Sarcopenia as a predictor of adverse outcomes in patients with acute coronary syndrome: A prospective cohort study.

Fortunato Wenize Suyane Lopes, Silva-Filho Jorge Zacarias, Costa Alves Yasmin Luana, Silva Maria Eduarda Paiva, Diniz Alcides da Silva, Pinho Cláudia Porto Sabino, Cabral Poliana Coelho

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVE

Sarcopenia has emerged as a systemic marker of biological vulnerability; however, its prognostic role in acute coronary syndrome (ACS) remains poorly explored, particularly in middle-income countries. This study investigated whether sarcopenia was associated with mortality and new coronary events during a 24-month follow-up period.

METHODS PROCEDURES: This prospective cohort study included 149 individuals aged ≥50 years admitted to a university hospital with a clinical diagnosis of ACS. Sarcopenia was defined according to the EWGSOP2 criteria, based on reduced handgrip strength and low muscle mass estimated by bioelectrical impedance analysis. Outcomes included all-cause mortality and new coronary events, obtained from medical records and 24-month follow-up. Survival analyses were estimated using the Kaplan-Meier method and compared using the log-rank test. The association between sarcopenia, mortality, and new coronary events was assessed using Cox proportional hazards regression models, with crude and adjusted hazard ratios (HRs).

RESULTS

The prevalence of sarcopenia was 14.8%, while 51.7% of participants had excess weight. At 24 months, follow-up data were available for 113 participants (24.2% loss to follow-up), among these, 30.1% experienced new coronary events and 12.4% died. Patients with sarcopenia had lower overall survival and a higher cumulative incidence of new coronary events (log-rank p < 0.05). In Cox regression models adjusted for age and sex, sarcopenia was associated with a higher risk of mortality (HR = 7.2; 95%CI: 1.9-16.9) and new coronary events (HR = 2.5; 95%CI: 1.1-6.0).

CONCLUSIONS

Sarcopenia was associated with a higher risk of mortality and new coronary events after adjustment for age and sex during the 24-month follow-up, supporting its potential relevance as a prognostic marker in patients with ACS. Sarcopenia screening may contribute to prognostic stratification and help identify patients who may benefit from further nutritional and functional assessment.

Для цитирования: Fortunato Wenize Suyane Lopes, Silva-Filho Jorge Zacarias, Costa Alves Yasmin Luana, Silva Maria Eduarda Paiva, Diniz Alcides da Silva, Pinho Cláudia Porto Sabino, Cabral Poliana Coelho. Sarcopenia as a predictor of adverse outcomes in patients with acute coronary syndrome: A prospective cohort study.. Clinical nutrition ESPEN. 2026. DOI: 10.1016/j.clnesp.2026.105069.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.